Absorption and disposition of ranitidine hydrochloride in rat and dog

Xenobiotica

Volumn 26, Issue 9, 1996, Pages 947-956

  Eddershaw, P J ^a   Chadwick, A P ^a,b   Higton, D M ^a   Fenwick, S H ^a   Linacre, P ^a   Jenner, W N ^a   Bell, J A ^a   Manchee, G R ^a  

^a GLAXOSMITHKLINE   (United Kingdom)

^b UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

DRUG METABOLITE; RANITIDINE; RANITIDINE N OXIDE; RANITIDINE SULFOXIDE;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DEMETHYLATION; DOG; DRUG ABSORPTION; DRUG BLOOD LEVEL; DRUG CLEARANCE; DRUG DISPOSITION; DRUG METABOLISM; DRUG OXIDATION; DRUG URINE LEVEL; FEMALE; INTRAVENOUS DRUG ADMINISTRATION; MALE; NONHUMAN; ORAL DRUG ADMINISTRATION; RAT; URINARY EXCRETION;

ANIMALIA; CANIS FAMILIARIS;

EID: 0029807480     PISSN: 00498254     EISSN: None     Source Type: Journal    
DOI: 10.3109/00498259609052496     Document Type: Article

References (12)

1. CROSS, D. M., 1991, Isolated hepatocytes as a model for ranitidine metabolism: in vivo and in vitro correlations in the rat, dog and guinea-pig. PhD thesis, University of Hertfordshire.
2. CROSS, D. M., BELL, J. A. and WILSON, K., 1995, Kinetics of ranitidine metabolism in dog and rat isolated hepatocytes. Xenobiotica, 25, 367-375.
3. DAVIES, B. and MORRIS, T., 1993, Physiological parameters in laboratory animals and humans. Pharmaceutical Research, 10, 1093-1095.
4. GARG, C., WEIDLER, D. J. and ESHELMAN, F. N., 1983, Ranitidine bioavailability and kinetics in normal male subjects. Clinical Pharmacology and Therapeutics, 33, 445-452.
5. JENNER, W. N., MARTIN, L. E., WILLOUGHBY, B. A. and FELLOWS, I., 1981, The development of a radioimmunoassay for ranitidine in biological fluids. Life Sciences, 28, 1323-1329.
6. 3H]-ranitidine in man. In Abstracts of the European Drug Metabolism Workshop, Guildford, England. No. P1/13 (Basingstoke: Taylor and Francis).
7. MARTIN, L. E., BELL, J. A., CAREY, P. F., DALLAS, F. A. A., DIXON, G. T. and JENNER, W. N., 1982, A review of pharmacokinetics and metabolism of ranitidine in animals and man. In The Clinical Use of Ranitidine (Oxford: Medicine Publ. Foundation), pp. 23-31.
8. 2-receptor antagonists. In Sulphur-Containing Drugs and Related Organic Compounds, vol. 3, Part A: Metabolism and Pharmacokinetics of Sulphur-Containing Drugs, edited by L. A. Damani (Chichester: Ellis Horwood), pp. 53-86.
9. SUTTLE, B. and BROUWER, K. L. R., 1991, Contribution of enterohepatic recirculation to ranitidine pharmacokinetics in rats. Pharmacology Research, 8, 259.
10. SUTTLE, B. and BROUWER, K. L. R., 1994, Bile flow but not enterohepatic recirculation influences the pharmacokinetics of ranitidine in the rat. Drug Metabolism and Disposition, 22, 224-232.
11. VARUGHESE, A. and LEE, C.-S. C., 1983, Disposition kinetics of ranitidine in rats. Drugs in Experimental and Clinical Research, IX, 837-842.
12. 2-receptor antagonist. New England Journal of Medicine, 309, 1368-1373.